MIMEDX GROUP, INC.

For the period ended Dec 31, 2025. Filed Feb 25, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 25, 2026

MDXG$3.37+1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets – As of

(in thousands, except share data)

	December 31,
	2025	2024
ASSETS
Current assets:
Cash and cash equivalents	$166,121	$104,416
Accounts receivable, net	75,707	55,828
Inventory	25,340	23,807
Other current assets	10,303	7,835
Total current assets	277,471	191,886
Property and equipment, net	4,713	5,944
Deferred tax assets	19,596	28,306
Goodwill	19,441	19,441
Intangible assets, net	14,158	11,626
Other assets	7,274	6,712
Total assets	$342,653	$263,915
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long term debt	$1,500	$1,000
Accounts payable	14,528	7,409
Accrued compensation	31,065	23,667
Accrued expenses	11,383	9,012
Other current liabilities	5,790	4,507
Total current liabilities	64,266	45,595
Long term debt, net	16,467	17,830
Other liabilities	5,372	7,383
Total liabilities	$86,105	$70,808
Stockholders’ equity
Common stock; $.001 par value; 250,000,000 shares authorized, 148,093,920 issued and outstanding at December 31, 2025 and 146,932,032 issued and outstanding at December 31, 2024	148	147
Additional paid-in capital	299,081	284,219
Accumulated deficit	(42,681)	(91,259)
Total stockholders’ equity	256,548	193,107
Total liabilities and stockholders’ equity	$342,653	$263,915

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.